Serum creatinine does not improve early classification of ischemic stroke caused by small artery occlusion

Adam B Cohen1, Robert A Taylor, Steven R Messé

  • 1Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.

Insights

Impaired kidney function does not help identify small-artery occlusion (SAO) stroke subtypes. Lacunar syndrome is only a reliable predictor of SAO in diabetic patients with acute ischemic stroke.

Area of Science:

  • Neurology
  • Nephrology
  • Cardiovascular Research

Background:

  • Accurate ischemic stroke subtyping is crucial but challenging.
  • Microvascular disease is a systemic condition often linked to impaired renal function.
  • Small-artery occlusion (SAO) is a major subtype of ischemic stroke.

Purpose of the Study:

  • To investigate the correlation between impaired renal function and the small-artery occlusion (SAO) stroke subtype.
  • To determine if serum creatinine levels can predict SAO in acute ischemic stroke patients.
  • To assess the utility of lacunar syndrome as a predictor of SAO, particularly in diabetic patients.

Main Methods:

  • Retrospective cohort study of consecutive ischemic stroke patients.
  • Analysis of clinical and laboratory data at admission.
  • Comparison of baseline serum creatinine levels with final stroke subtype determination.

Main Results:

  • No significant correlation was found between elevated serum creatinine and the SAO subtype.
  • Lacunar syndrome was the most helpful predictor of SAO, but only in patients with diabetes.
  • The positive predictive value of lacunar syndrome for SAO in diabetic patients was 67%.

Conclusions:

  • Impaired renal function, indicated by serum creatinine, does not aid in the early identification of SAO stroke.
  • Lacunar syndrome is an effective early indicator of SAO exclusively in diabetic stroke patients.
  • Current biomarkers and clinical signs have limitations in accurately subtyping acute ischemic stroke, especially SAO.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.